Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Beacon Pharmaceuticals Revenue

Beacon Pharmaceuticals had revenue of 3.80B BDT in the quarter ending March 31, 2026, with 19.65% growth. This brings the company's revenue in the last twelve months to 15.57B, up 30.15% year-over-year. In the fiscal year ending June 30, 2025, Beacon Pharmaceuticals had annual revenue of 12.54B with 17.20% growth.

• Revenue (ttm): 15.57B
• Revenue Growth: +30.15%
• P/S Ratio: 1.70
• Revenue / Employee: 3.26M
• Employees: 4,771
• Market Cap: 26.40B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.54B	1.84B	17.20%
Jun 30, 2024	10.70B	2.19B	25.76%
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%
Jun 30, 2021	7.12B	1.53B	27.37%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error